Featured Image for MUMO Studio
MUMO Studio Launches a Campaign for DUBIUM, a Survival Thriller Game
18 nov. 2021 10h56 HE | MUMO Studio
CYPRESS, Calif., Nov. 18, 2021 (GLOBE NEWSWIRE) -- MUMO Studio has launched a Kickstarter campaign today to support the development and help build a community around their debut title, DUBIUM. This...
AB Science annonce a
AB Science annonce aujourd’hui que les dernières données cliniques de survie à long terme dans la SLA seront présentées au colloque international 2021 de la SLA et des maladies du motoneurone
02 sept. 2021 11h59 HE | AB Science
COMMUNIQUE DE PRESSE AB SCIENCE PRESENTERA LES DERNIERES DONNEES CLINIQUES DE SURVIE A LONG TERME DANS LA SCLEROSE LATERALE AMYOTROPHIQUE AU COLLOQUE INTERNATIONAL 2021 DE LA SCLEROSE LATERALE...
AB Science announced
AB Science announced today that latest clinical data on long-term survival analyses in ALS will be presented at the 2021 symposium on ALS/MND
02 sept. 2021 11h59 HE | AB Science
PRESS RELEASE AB SCIENCE TO PRESENT LATEST CLINICAL DATA ON LONG-TERM SURVIVAL ANALYSES IN AMYOTROPHIC LATERAL SCLEROSIS AT THE 2021 INTERNATIONAL SYMPOSIUM ON ALS/MND Paris, 2 September, 2021, 6pm...
Resilient Housing Is Needed More Than Ever: But Is It Too Late?
28 juil. 2021 10h56 HE | Green Builder Media
Lake City, Colo., July 28, 2021 (GLOBE NEWSWIRE) -- Join Green Builder Media on August 3 at 2:00 pm EDT for the next in its housing-related webinar series: “Why Building and Designing Homes With...
AB Science annonce l
AB Science annonce la publication de nouvelles données de survie montrant que le masitinib prolongeait la survie dans la SLA de 25 mois par rapport au placebo
19 juil. 2021 12h12 HE | AB Science
COMMUNIQUE DE PRESSE DE NOUVELLES DONNEES À LONG TERME SUR UNE DUREE DE 75 MOIS ONT MONTRÉ QUE LE MASITINIB PROLONGEAIT LA SURVIE DANS LA SCLÉROSE LATÉRALE AMYOTROPHIQUE DE 25 MOIS PAR RAPPORT AU...
AB Science announces
AB Science announces the publication of new survival data showing that masitinib extended survival in ALS by 25 months relative to placebo
19 juil. 2021 12h12 HE | AB Science
PRESS RELEASE LONG-TERM FOLLOW-UP OF 75 MONTHS SHOWED THAT MASITINIB EXTENDED SURVIVAL IN AMYOTROPHIC LATERAL SCLEROSIS BY 25 MONTHS RELATIVE TO PLACEBO, PROVIDED THAT TREATMENT STARTS EARLY...
‘Jeremy Longtail and the Hunt for Mongolia’ is more than a simple animal tale
27 nov. 2020 00h00 HE | Archway Publishing
ELLICOTT CITY, Md., Nov. 27, 2020 (GLOBE NEWSWIRE) -- Jeremy Longtail, a gerbil, is determined to find Mongolia, the native home of his ancestors. Readers can follow him as he travels the wild road...
Revised first RELEASE SLIDE (Nov 24)
Modus Research: Canadian Businesses Are Much More Optimistic About Long-Term Survival Than in the Spring
24 nov. 2020 15h16 HE | Modus Research Inc.
TORONTO, Nov. 24, 2020 (GLOBE NEWSWIRE) -- The latest findings from The Business Monitor, which surveyed of over 1,000 Canadian managers and executives, show a big upswing in business leaders’...
Bill Jones recounts his 51 years of catering all over the world in a collection of vignettes
15 oct. 2020 05h00 HE | Balboa Press
PALM SPRINGS, Calif., Oct. 15, 2020 (GLOBE NEWSWIRE) -- Recent release “My Wild Ride on a Carousel: (By the Caterer Who Couldn’t Cook)” (published by Balboa Press) is an inspiring true story of...
Witness a father’s love for his son in ‘Life Marrow’
01 oct. 2020 00h07 HE | Balboa Press AU
SYDNEY, Oct. 01, 2020 (GLOBE NEWSWIRE) -- Destin Writer shares the story of his two-year-old son who was diagnosed with leukemia in 2017 and the challenges he faced as a father in his memoir “Life...